What is the share price of Krebs Biochemicals and Industries Ltd (KREBSBIO) today?
The share price of KREBSBIO as on 10th July 2025 is ₹82.71. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Krebs Biochemicals and Industries Ltd (KREBSBIO) share?
The past returns of Krebs Biochemicals and Industries Ltd (KREBSBIO) share are- Past 1 week: -4.49%
- Past 1 month: -18.40%
- Past 3 months: 14.22%
- Past 6 months: -9.17%
- Past 1 year: 4.45%
- Past 3 years: -19.03%
- Past 5 years: 11.24%
What are the peers or stocks similar to Krebs Biochemicals and Industries Ltd (KREBSBIO)?
The peers or stocks similar to Krebs Biochemicals and Industries Ltd (KREBSBIO) include:What is the market cap of Krebs Biochemicals and Industries Ltd (KREBSBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krebs Biochemicals and Industries Ltd (KREBSBIO) is ₹178.33 Cr as of 10th July 2025.What is the 52 week high and low of Krebs Biochemicals and Industries Ltd (KREBSBIO) share?
The 52-week high of Krebs Biochemicals and Industries Ltd (KREBSBIO) is ₹129.07 and the 52-week low is ₹66.12.What is the PE and PB ratio of Krebs Biochemicals and Industries Ltd (KREBSBIO) stock?
The P/E (price-to-earnings) ratio of Krebs Biochemicals and Industries Ltd (KREBSBIO) is -6.62. The P/B (price-to-book) ratio is 16.54.Which sector does Krebs Biochemicals and Industries Ltd (KREBSBIO) belong to?
Krebs Biochemicals and Industries Ltd (KREBSBIO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Krebs Biochemicals and Industries Ltd (KREBSBIO) shares?
You can directly buy Krebs Biochemicals and Industries Ltd (KREBSBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Krebs Biochemicals and Industries Ltd
KREBSBIO Share Price
KREBSBIO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
KREBSBIO Performance & Key Metrics
KREBSBIO Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-6.62 | 16.54 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.59 | 6.40 | 0.79% |
KREBSBIO Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
KREBSBIO Company Profile
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
KREBSBIO Forecast
KREBSBIO Forecasts
KREBSBIO
KREBSBIO
Income
Balance Sheet
Cash Flow
KREBSBIO Income Statement
KREBSBIO Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 3.65 | 34.13 | 48.20 | 33.78 | 54.32 | 60.86 | 52.75 | 50.87 | 44.02 | 44.02 | ||||||||||
Raw Materials | 1.34 | 17.12 | 20.99 | 19.18 | 25.62 | 46.18 | 19.81 | 5.52 | 58.34 | 58.35 | ||||||||||
Power & Fuel Cost | 0.70 | 8.62 | 11.70 | 10.28 | 15.91 | 22.23 | 14.80 | 22.01 | ||||||||||||
Employee Cost | 5.63 | 11.49 | 14.41 | 14.56 | 15.30 | 14.96 | 15.54 | 16.17 | ||||||||||||
Selling & Administrative Expenses | 2.52 | 3.43 | 3.83 | 4.01 | 3.39 | 6.11 | 4.57 | 4.50 | ||||||||||||
Operating & Other expenses | 1.78 | 1.98 | 6.59 | 3.94 | 11.05 | 4.22 | 13.20 | 10.95 | ||||||||||||
EBITDA | -8.32 | -8.51 | -9.32 | -18.19 | -16.95 | -32.84 | -15.17 | -8.28 | -14.32 | -14.33 | ||||||||||
Depreciation/Amortization | 4.23 | 4.15 | 4.40 | 4.68 | 5.12 | 6.30 | 6.56 | 6.77 | 6.69 | 6.69 | ||||||||||
PBIT | -12.55 | -12.66 | -13.72 | -22.87 | -22.07 | -39.14 | -21.73 | -15.05 | -21.01 | -21.02 | ||||||||||
Interest & Other Items | 3.49 | 5.17 | 6.29 | 6.00 | 6.28 | 5.39 | 2.97 | 4.69 | 5.91 | 5.91 | ||||||||||
PBT | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -26.92 | -26.93 | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | ||||||||||
Net Income | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -26.94 | -26.95 | ||||||||||
EPS | -11.56 | -12.53 | -12.97 | -16.67 | -15.07 | -21.63 | -11.46 | -9.16 | -12.49 | -12.50 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
KREBSBIO Company Updates
KREBSBIO Stock Peers
KREBSBIO Past Performance & Peer Comparison
KREBSBIO Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Krebs Biochemicals and Industries Ltd | -6.62 | 16.54 | — |
Sun Pharmaceutical Industries Ltd | 36.50 | 5.50 | 0.96% |
Cipla Ltd | 22.64 | 3.82 | 1.08% |
Torrent Pharmaceuticals Ltd | 59.13 | 14.89 | 0.18% |
KREBSBIO Stock Price Comparison
Compare KREBSBIO with any stock or ETFKREBSBIO Holdings
KREBSBIO Shareholdings
KREBSBIO Promoter Holdings Trend
KREBSBIO Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
KREBSBIO Institutional Holdings Trend
KREBSBIO Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
KREBSBIO Shareholding Pattern
KREBSBIO Shareholding Pattern
KREBSBIO Shareholding History
KREBSBIO Shareholding History
smallcases containing KREBSBIO stock
smallcases containing KREBSBIO stock
Looks like this stock is not in any smallcase yet.
KREBSBIO Events
KREBSBIO Events
KREBSBIO Dividend Trend
KREBSBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
KREBSBIO Dividend Trend
KREBSBIO has not given any dividends in last 5 years
KREBSBIO Dividends
KREBSBIO Dividends
KREBSBIO Stock News & Opinions
KREBSBIO Stock News & Opinions
Net Loss of Krebs Biochemicals & Industries reported to Rs 8.27 crore in the quarter ended March 2025 as against net loss of Rs 5.85 crore during the previous quarter ended March 2024. Sales declined 49.04% to Rs 6.10 crore in the quarter ended March 2025 as against Rs 11.97 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 26.94 crore in the year ended March 2025 as against net loss of Rs 19.73 crore during the previous year ended March 2024. Sales declined 14.10% to Rs 43.31 crore in the year ended March 2025 as against Rs 50.42 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales6.1011.97 -49 43.3150.42 -14 OPM %-88.69-26.07 --34.70-17.29 - PBDT-6.68-4.18 -60 -20.23-12.96 -56 PBT-8.25-5.85 -41 -26.92-19.73 -36 NP-8.27-5.85 -41 -26.94-19.73 -37 Powered by Capital Market - Live
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
Net Loss of Krebs Biochemicals & Industries reported to Rs 7.74 crore in the quarter ended December 2024 as against net loss of Rs 4.98 crore during the previous quarter ended December 2023. Sales declined 11.63% to Rs 11.47 crore in the quarter ended December 2024 as against Rs 12.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales11.4712.98 -12 OPM %-41.06-16.10 - PBDT-6.02-3.25 -85 PBT-7.74-4.98 -55 NP-7.74-4.98 -55 Powered by Capital Market - Live
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
Uflex Ltd, Raghav Productivity Enhancers Ltd, Ruby Mills Ltd and Shree Rama Multi-Tech Ltd are among the other losers in the BSE's 'B' group today, 28 November 2024.Krebs Biochemicals & Industries Ltd tumbled 10.00% to Rs 112.86 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 15166 shares were traded on the counter so far as against the average daily volumes of 15331 shares in the past one month.Uflex Ltd crashed 6.75% to Rs 540.05. The stock was the second biggest loser in 'B' group.On the BSE, 15520 shares were traded on the counter so far as against the average daily volumes of 5142 shares in the past one month.Raghav Productivity Enhancers Ltd lost 6.20% to Rs 1559.5. The stock was the third biggest loser in 'B' group.On the BSE, 9936 shares were traded on the counter so far as against the average daily volumes of 7019 shares in the past one month.Ruby Mills Ltd shed 5.32% to Rs 271.4. The stock was the fourth biggest loser in 'B' group.On the BSE, 4250 shares were traded on the counter so far as against the average daily volumes of 5650 shares in the past one month.Shree Rama Multi-Tech Ltd fell 5.00% to Rs 47.32. The stock was the fifth biggest loser in 'B' group.On the BSE, 2.49 lakh shares were traded on the counter so far as against the average daily volumes of 1.68 lakh shares in the past one month.Powered by Capital Market - Live
Ruby Mills Ltd, 3P Land Holdings Ltd, Godavari Biorefineries Ltd and RPP Infra Projects Ltd are among the other gainers in the BSE's 'B' group today, 26 November 2024.Krebs Biochemicals & Industries Ltd spiked 19.99% to Rs 118.23 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 74997 shares were traded on the counter so far as against the average daily volumes of 7351 shares in the past one month. Ruby Mills Ltd surged 19.99% to Rs 249.1. The stock was the second biggest gainer in 'B' group. On the BSE, 15233 shares were traded on the counter so far as against the average daily volumes of 1676 shares in the past one month. 3P Land Holdings Ltd soared 19.99% to Rs 65.73. The stock was the third biggest gainer in 'B' group. On the BSE, 24431 shares were traded on the counter so far as against the average daily volumes of 7340 shares in the past one month. Godavari Biorefineries Ltd advanced 17.00% to Rs 328.9. The stock was the fourth biggest gainer in 'B' group. On the BSE, 92054 shares were traded on the counter so far as against the average daily volumes of 1.03 lakh shares in the past one month. RPP Infra Projects Ltd spurt 16.53% to Rs 194.25. The stock was the fifth biggest gainer in 'B' group. On the BSE, 93348 shares were traded on the counter so far as against the average daily volumes of 13019 shares in the past one month. Powered by Capital Market - Live
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September 2024 as against net loss of Rs 3.57 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 14.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.8614.89 -14 OPM %-21.15-6.04 - PBDT-4.05-1.86 -118 PBT-5.76-3.57 -61 NP-5.76-3.57 -61 Powered by Capital Market - Live
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024 as against net loss of Rs 5.33 crore during the previous quarter ended June 2023. Sales rose 21.83% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 10.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8910.58 22 OPM %-16.99-24.76 - PBDT-3.48-3.68 5 PBT-5.17-5.33 3 NP-5.17-5.33 3 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 5.44%, vs industry avg of 10.1%
Over the last 5 years, market share stayed at 0.01%